$30MSeries A, 9 January 2026
Series A funds clinical development and regulatory and commercial milestones.
- Amount
- $30M
- Stage
- Series A
- Announced
- 9 January 2026
- Lead
- Longitude Capital
- Other investors
- Vensana Capital, Atypical Ventures, Neotribe Ventures, Boutique Venture Partners
- Use of funds
- Series A funds clinical development and regulatory and commercial milestones.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Ventaris Surgical: $30 Million Series A Raised To Develop Next-Generation Kidney Stone Treatment System pulse2.com
Ventaris Surgical: $30 Million Series A Raised To Develop Next-Generation Kidney Stone Treatment System pulse2.com